Skip to main content

Table 2 Studies included in each network meta-analysis

From: Patient characteristics as effect modifiers for psoriasis biologic treatment response: an assessment using network meta-analysis subgroups

Studies

All licensed doses (N = 69)

Patients with no previous biologic use (< 25% had previous use)

(N = 34)

Patients with PASI score ≤ 25 (N = 59)

Patients with weight ≤ 90 kg (N = 28)

White patients (≥ 90% white) (N = 42)

AMAGINE1 2016

 

 

AMAGINE2 2015

 

 

AMAGINE3 2015

Nakagawa 2016

 

 

Papp 2012

 

 

CHAMPION 2008

 

Goldminz 2015

 

  

Cai 2016

 

 

REVEAL 2008

 

Asahina 2010

  

 

Gordon 2006

 

 

XPLORE 2015

 

 

Bissonnette 2013

 

 

VOYAGE1 2017

  

VOYAGE2 2017

  

PSOR005 2012

 

 

ESTEEM1 2015

 

 

ESTEEM2 2015

 

 

Ohtsuki 2017

 

LIBERATE 2016

Leonardi 2003

 

  

Gottlieb 2003

 

 

Papp 2005

 

 

VandeKerkhof 2008

 

Bagel 2012

  

Bachelez 2015

 

Tyring 2006

 

  

PRISTINE 2013

 

M10114 2011

 

M10315 2011

 

reSURFACE2

PIECE 2016

 

Yang 2012

 

 

EXPRESS 2005

 

 

Chaudhari 2001

SPIRIT 2004

 

 

EXPRESSII 2007

 

Torii 2010

  

 

RESTORE1 2011

UNCOVER1 2016

 

 

UNCOVER2 2015

 

UNCOVER3 2015

 

IXORAS 2017

FEATURE 2015

 

 

ERASURE 2014

 

 

FIXTURE 2014

 

JUNCTURE 2015

 

CLEAR 2015

 

PEARL 2011

 

PHOENIX1 2008

 

 

PHOENIX2 2008

 

 

LOTUS 2013

 

ACCEPT 2010

 

Igarashi 2012

 

 

BRIDGE 2017

 

Caproni 2009

 

 

Gisondi 2008

 

 

Meffert

   

PappD 2015

   

ReSURFACE1

 

ultIMMA1

    

ultIMMA2

    

METOP

 

Krueger

 

  

Reich 2012

CIMPACT 2018

 

CIMPASI1 2018

 

 

CIMPASI2 2018

 

 

UNVEIL